High level MYCN amplification and distinct methylation signature define an aggressive subtype of spinal cord ependymoma

MLA

Mark Raffeld, et al. “High Level MYCN Amplification and Distinct Methylation Signature Define an Aggressive Subtype of Spinal Cord Ependymoma.” Acta Neuropathologica Communications, vol. 8, no. 1, July 2020, pp. 1–11. EBSCOhost, https://doi.org/10.1186/s40478-020-00973-y.

APA

Mark Raffeld, Zied Abdullaev, Svetlana D. Pack, Liqiang Xi, Sushma Nagaraj, Nicole Briceno, Elizabeth Vera, Stefania Pittaluga, Osorio Lopes Abath Neto, Martha Quezado, Kenneth Aldape, Terri S. Armstrong, & Mark R. Gilbert. (2020). High level MYCN amplification and distinct methylation signature define an aggressive subtype of spinal cord ependymoma. Acta Neuropathologica Communications, 8(1), 1–11. https://doi.org/10.1186/s40478-020-00973-y

Chicago

Mark Raffeld, Zied Abdullaev, Svetlana D. Pack, Liqiang Xi, Sushma Nagaraj, Nicole Briceno, Elizabeth Vera, et al. 2020. “High Level MYCN Amplification and Distinct Methylation Signature Define an Aggressive Subtype of Spinal Cord Ependymoma.” Acta Neuropathologica Communications 8 (1): 1–11. doi:10.1186/s40478-020-00973-y.